Bliss GVS Pharma Ltd

NSE: BLISSGVS · BSE: 506197 · Pharmaceuticals & Biotechnology · 40 announcements

Share price: ₹681.55
Market cap: ₹7,247 Cr
Revenue (annual): ₹927.1 Cr
Net profit (annual): ₹129.1 Cr
P/E (TTM): 53.2×Sector 47.3×
Promoter holding: 35.01%-0.35% QoQ
FII holding: 8.07%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Open Offer 3 Employee Stock Options 3 Annual General Meeting 3 Other Announcement 2 Capital Structure Change 2 Management Change 1 Financial Results 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

23 Jul 2026 12:58 IST BSE

Other Announcement

Bliss GVS Pharma Other Announcement

Bliss GVS Pharma is transferring unclaimed dividends from 2018-2019 and related shares to the IEPF. Shareholders are notified to claim these funds by October 27, 2026.

Read the filing ↗

15 Jul 2026 13:54 IST BSE

Other Announcement

Bliss GVS Pharma Other Announcement

Bliss GVS Pharma updated contact details for KMPs authorized to determine and report material events. This administrative update ensures compliance with SEBI LODR Regulation 30(5).

Read the filing ↗